Previous research showed that cancer patients with diabetes may have increased tumor cell proliferation and metastatic capacity as a consequence of the high insulin or increased free insulin-like growth factor (IGF-1) levels in hyperinsulinemic states [29]. This evidence concerns the gene INS and neoplasm.